The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples